Concord Biotech Limited
Concord Biotech Limited is a mainboard IPO raising ₹1,551 Cr at ₹705 – ₹741 a share. It listed on 18 Aug 2023 and trades at ₹1,255 today, +69.4% against its issue price of ₹741. It was subscribed 25× in total.
24.9 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
What happened after it listed
Computed from our own daily closes — never from the exchange’s listing-price field, which is missing for about 47% of listed issues.
Multi-horizon returns — listing day, one week, one month, three, six and a year — are being built and will appear here.
How its cohort has done
57 mainboard issues listed in 2023 that we can price today. This is the group this issue belongs to.
Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →
Everything this company files, from here on
A newly listed company starts filing results, orders and board decisions immediately. We summarise each one and send it to your WhatsApp.